Nabriva Therapeutics, a biopharmaceutical company, signed an eight-year sublease for 15,044 square feet in the office building at 1000 Continental Dr. in King of Prussia, PA.
Nabriva Therapeutics, a biopharmaceutical company, signed an eight-year sublease for 15,044 square feet in the office building at 1000 Continental Dr. in King of Prussia, PA.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In